Considering the relationship between prognosis and gene expression, two biomarkers associated with GBM, including TREM1 and APOC1, were selected from the twenty candidate biomarkers using lasso-cox dimensionality reduction for further analysis (Figure 3B). This evidence concerns the gene APOC1 and glioblastoma.